T Lymphocyte News and Research

RSS
The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Type I interferons play crucial role in fending off SARS-CoV-2

Type I interferons play crucial role in fending off SARS-CoV-2

Stress accelerates aging of the immune system

Stress accelerates aging of the immune system

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Impact of cannabidiol on cellular innate immune responses to SARS-CoV-2 genes

Impact of cannabidiol on cellular innate immune responses to SARS-CoV-2 genes

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Study reveals serum proteomic signatures of long COVID patients

Study reveals serum proteomic signatures of long COVID patients

Third BNT162b2 dose elicits more durable immune response than second dose

Third BNT162b2 dose elicits more durable immune response than second dose

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients

Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

Improved seroprevalence and antibody response after third COVID-19 vaccination

Improved seroprevalence and antibody response after third COVID-19 vaccination

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages